QPPV.COM KNOWLEDGE ASSESSMENT

Safety Specification: Pharmacovigilance and EU Risk Management Assessment

Test your understanding of the concepts covered by Safety Specification.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why can the same adverse reaction have different significance for two medicinal products?

Because adverse reactions are classified solely according to their medical terminology Because risk significance depends on context, including severity, frequency, reversibility, treatability and the therapeutic benefit Because only the product's formulation determines whether an event is important Because an adverse reaction is important only when it occurs in clinical trials

Question 2 of 10 Which feature distinguishes missing information from an important potential risk?

Missing information concerns an important knowledge gap, whereas a potential risk concerns a possible association with an adverse outcome Missing information always concerns a confirmed causal relationship Potential risks are limited to clinical trial findings, whereas missing information comes only from literature There is no conceptual distinction between the two categories

Question 3 of 10 Which combination is required for an important identified risk?

A possible association and a theoretical mechanism, regardless of clinical importance Sufficient evidence of a causal association and importance for ongoing risk management A single report and a requirement for additional risk minimisation Evidence that the event occurs only in a population with missing information

Question 4 of 10 Which situation most clearly warrants escalation and prompt regulatory consideration?

A theoretical concern with negligible expected exposure and no plausible mechanism A serious signal with potential public health impact that may require urgent communication or risk minimisation A routine adverse reaction already adequately addressed by standard product information A completed study whose findings have been fully incorporated into the RMP

Question 5 of 10 Which evidence strategy is most appropriate when characterising a safety concern?

Rely exclusively on spontaneous reports because they reflect real-world use Use the totality of available evidence, including clinical, non-clinical, epidemiological, literature, post-marketing and regulatory information as relevant Give priority to the most recent data and disregard earlier evidence Use only evidence that supports the proposed classification

Question 6 of 10 What is the most appropriate role of signal management in relation to the Safety Specification?

It is separate from the RMP and should not influence the Safety Specification It may lead to new concerns, reclassification of risks or resolution of uncertainties It is used only to remove risks from the Safety Specification It replaces the need for periodic benefit-risk evaluation

Question 7 of 10 A serious adverse event has a strong causal association with a product but is extremely rare, readily preventable through routine prescribing information and does not materially affect the product's benefit-risk balance. Which interpretation is most appropriate?

It must be an important identified risk because it is serious It must be an important potential risk because it is rare Causality and seriousness do not automatically make it an important risk; its overall risk-management relevance must be assessed It should automatically be classified as missing information

Question 8 of 10 Which documentation most directly demonstrates traceability from a safety concern to RMP actions?

A list of all employees who have accessed the RMP A cross-reference matrix mapping each concern to specific pharmacovigilance activities, risk minimisation measures, rationale and timelines A general company safety policy without product-specific references A summary of product sales by country

Question 9 of 10 Which intervention is most clearly an additional risk minimisation measure rather than a pharmacovigilance activity?

A pregnancy registry A targeted observational cohort study An educational programme for healthcare professionals A periodic review of spontaneous reports

Question 10 of 10 Which situation best illustrates an important potential risk?

A confirmed serious interaction demonstrated consistently in trials and post-marketing data A clinically relevant signal with plausible association, but insufficient evidence to confirm causality A population for which no safety information is available, regardless of clinical relevance A routine, mild adverse reaction already adequately described in product information

Safety Specification: Pharmacovigilance and EU Risk Management Assessment

Cookie Settings